Title of article
Macular Infarction following Intravitreal Clindamycin Injection : A Case Report
Author/Authors
Hedayatfar, Alireza Eye Research Center - The Five Senses Institute - Rassoul Akram Hospital - Iran University of Medical Sciences, Tehran, Iran , Zand, Amin Eye Research Center - The Five Senses Institute - Rassoul Akram Hospital - Iran University of Medical Sciences, Tehran, Iran , Faghihi, Hooshang Eye Research Center - Farabi Eye Hospital - Tehran University of Medical Sciences, Tehran, Iran , Gordiz, Arzhang Eye Research Center - The Five Senses Institute - Rassoul Akram Hospital - Iran University of Medical Sciences, Tehran, Iran , Abdi, Fatemeh Eye Research Center - The Five Senses Institute - Rassoul Akram Hospital - Iran University of Medical Sciences, Tehran, Iran
Pages
5
From page
349
To page
353
Abstract
Purpose: To report a case of Toxoplasma retinochoroiditis that was complicated by macular infarction following intravitreal clindamycin injection.
Methods: A 32‑year‑old otherwise healthy woman with the diagnosis of reactivation of Toxoplasma retinochoroiditis in her right eye, underwent
intravitreal clindamycin injection. Shortly after injection, the visual acuity deteriorated, and the fundus examination revealed an extensive
area of macular necrosis accompanied by vascular occlusion.
Results: The patient was observed. Unfortunately, the condition did not improve over time and resulted in a large area of retinal atrophy.
Conclusion: Macular infarction should be considered a rare but disastrous complication that can result in severe, irreversible visual loss.
Keywords
Clindamycin , Intravitreal injection , Macular infarction , Retinal toxicity , Toxoplasma retinochoroiditis
Journal title
Journal of Current Ophthalmology
Serial Year
2021
Record number
2717135
Link To Document